An effective vaccine against the virus that causes genital herpes has evaded researchers for decades.
While
an effective vaccine against the virus has been developed and will likely be approved, there are no drugs available to treat Ebola infections.
Fortunately, there is a very
effective vaccine against this virus.
Not exact matches
After all,
vaccines are
effective because they contain weak traces of the
viruses they protect
against.
A major trial last year showed a prototype
vaccine to be «very
effective»
against the deadly Ebola
virus, according to WHO, wich co-funded the study.
The method is relatively new, but far bacteria - based
vaccines have proven
effective: A seasonal flu
vaccine produced by VaxInnate successfully protected humans in clinical trials, and the company's recently tested swine flu
vaccine immunized mice
against the
virus.
Remarkably, the researchers also found that blocking this protein in mice protected them from the lethal effects of dengue
virus infection, an important finding given that an
effective vaccine against dengue has remained elusive, partly because there are four serotypes of the
virus that cause disease.
These
vaccines, however, are not
effective against viruses — so one solution is selecting parent fish with
virus - resistant traits to use as broodstock for salmon egg production.
One of the
vaccines, which is based on a recombinant vesicular stomatitis
virus expressing the glycoprotein of the Zaire strain of the Ebola
virus (VSV - ZEBOV), was recently shown to be extremely
effective with 100 per cent efficacy
against the lethal Ebola
virus disease in WHO - funded studies carried out in Guinea and Sierra Leone.
Kang's primary research focuses on designing and developing
effective vaccines against viral diseases such as influenza
virus and RSV, but he partnered with a university and research institutes in South Korea that wanted international collaborative projects to study if ginseng can be used to improve health and protect
against disease because of the potential benefit in fighting these
viruses.
A
vaccine that protects
against the
virus that causes Middle East respiratory syndrome (MERS) has been shown to be
effective in camels, a new study finds.
The researchers» find means that current diagnostic methods,
vaccines, and other treatment interventions should remain
effective against the
virus.
Moreover, they found that distinct HA mutations are evolving in the H7N9
virus indicating that currently recommended H7
vaccines would not be
effective against this newly emerged
virus.
«Right now, there is no
vaccine to protect
against the H7N9
virus, and our findings could guide efforts to develop
effective vaccine strategies,» Sasisekharan says.
While a
vaccine against the
virus is recently available commercially, its effectiveness is limited as it is not
effective against all the four dengue viral subtypes, and there are no alternative therapeutics yet.
The
vaccine, a DNA
vaccine, is safer and more
effective against Zika
virus and could offer more affordable long - term protection, researchers said.
The current
vaccine only protects
against one strain of the
virus and no
effective anti-viral medications exist for people who are already infected.
«These findings certainly raise optimism that the development of a safe and
effective vaccine against Zika
virus for humans may be successful,» he said.
So these data from monkeys, Dudley says, suggest «that a
vaccine could be quite
effective against the
virus.»
The study also affirms that a
vaccine that evokes the immune system to produce protective antibodies, such as ZIKV - 117, could be
effective against the
virus.
She noted that the Canadian researchers estimated that the flu
vaccine is 55 percent
effective against influenza B
viruses, which typically cause more infections late in the season.
This suggests that elder be superior to
vaccines in preventing flu, because flu
vaccines are only
effective against known strains of flu, whereas the
virus is continually mutating to new strains.»
The
vaccine is reasonably
effective, preventing infection in about 4 out of 5 vaccinated cats that are exposed to the same subtype of the
virus, and this is part of the problem; while the
vaccine protects
against the majority of strains found in North American cats, it is ineffective
against strains found in Europe.
Many
vaccines are 100 - percent
effective at producing antibodies, but the antibodies are not necessarily protective
against the
virus.
Such
vaccines are
effective against Bordetella, feline leukemia
virus, Chylamydophila felis, and feline immunodeficiency
virus.
Vaccines are not 100 %
effective, but will give your kitten a good degree of protection
against feline leukemia, respiratory diseases, flu type
viruses, feline panleukopenia, feline rabies and others.
Vaccines against the H3N8 influenza virus — which has existed in this country for more than a decade — are available, but there are differences in the genetic sequences of the two strains that suggest that these vaccines would be poorly effective, or ineffective in protecting dogs against the H3N2 virus infecting dogs in the Midwest
Vaccines against the H3N8 influenza
virus — which has existed in this country for more than a decade — are available, but there are differences in the genetic sequences of the two strains that suggest that these
vaccines would be poorly effective, or ineffective in protecting dogs against the H3N2 virus infecting dogs in the Midwest
vaccines would be poorly
effective, or ineffective in protecting dogs
against the H3N2
virus infecting dogs in the Midwest.»
What's different about this variant is not that the
vaccine isn't
effective against it, and not that adult dogs can get it, too (they can get older strains of parvo, too, but incidence is much lower than in puppies because adult dogs are easier to vaccinate effectively), but that that
virus has characteristics that make it harder to diagnose with the currently standard tests.
These four
vaccines are in the core category because they are safe, highly
effective, and the diseases they protect
against are severe (rabies and panleukopenia) or easily transmitted (the respiratory
viruses).
Fluvac Innovator ®
vaccines are the most trusted equine influenza
vaccines and help provide your horse with broad protection
against newly emerging and conventional equine influenza
virus strains as well as equine herpesvirus (EHV 1 and EHV 4).4 - 10 Zoetis regularly tests Fluvac Innovator to ensure its
vaccine continues to be
effective against emerging EIV isolates.
At this time, it is also unknown whether the current CIV
vaccine, developed to protect
against a different strain of the
virus (Influenza A H3N8), will be
effective in preventing Influenza A H3N2.
Vaccines also tend to be less
effective against A (H3N2) than other influenza
viruses.